BR100 Increased By (0.91%)
BR30 Increased By (1.13%)
KSE100 Increased By (0.9%)
KSE30 Increased By (1%)
AGHA 6.49 Increased By ▲ 0.11 (1.72%)
BECO 4.39 Increased By ▲ 0.04 (0.92%)
BML 62.30 Decreased By ▼ -0.25 (-0.4%)
BOP 31.49 Increased By ▲ 0.10 (0.32%)
CNERGY 11.86 Increased By ▲ 0.13 (1.11%)
CSIL 5.86 Decreased By ▼ -0.05 (-0.85%)
FCCL 62.35 Increased By ▲ 0.64 (1.04%)
FFL 14.95 Increased By ▲ 0.16 (1.08%)
FNEL 1.31 Increased By ▲ 0.07 (5.65%)
KEL 6.35 Increased By ▲ 0.03 (0.47%)
KOSM 5.86 Decreased By ▼ -0.04 (-0.68%)
LOTCHEM 24.72 Increased By ▲ 0.03 (0.12%)
MLCF 106.40 Increased By ▲ 2.47 (2.38%)
NBP 174.41 Increased By ▲ 1.09 (0.63%)
NCPL 52.21 Increased By ▲ 0.38 (0.73%)
NPL 55.00 Increased By ▲ 0.97 (1.8%)
OGDC 319.75 Increased By ▲ 3.88 (1.23%)
PACE 9.33 Increased By ▲ 0.07 (0.76%)
PAEL 35.93 Increased By ▲ 0.35 (0.98%)
PIBTL 13.90 Increased By ▲ 0.24 (1.76%)
PPL 228.61 Increased By ▲ 2.54 (1.12%)
PRL 81.70 Increased By ▲ 1.42 (1.77%)
PTC 47.15 Increased By ▲ 0.51 (1.09%)
SSGC 24.05 Increased By ▲ 0.23 (0.97%)
TBL 9.25 Increased By ▲ 0.01 (0.11%)
TELE 7.54 Decreased By ▼ -0.01 (-0.13%)
TPL 25.00 Increased By ▲ 0.46 (1.87%)
TPLP 13.15 Increased By ▲ 0.16 (1.23%)
TREET 26.03 Increased By ▲ 0.05 (0.19%)
TRG 53.80 Increased By ▲ 0.47 (0.88%)
World

Greece limits use of AstraZeneca vaccine to people over 30

  • Europe's medicines regulator said this week it found rare cases of blood clots among some adult recipients of the shot, although the vaccine's advantages still outweighed its risks.
  • Greece has reported 288,230 cases of COVID-19 and a total of 8,680 deaths. It has administered 378,997 doses of the AstraZeneca vaccine so far and ordered another 1.35 million doses.
Published Updated
By

ATHENS: Greece will limit use of the AstraZeneca COVID-19 vaccine to people above age 30 following rare cases of blood clots, its national vaccinations committee said on Friday, falling into line with other European countries.

Europe's medicines regulator said this week it found rare cases of blood clots among some adult recipients of the shot, although the vaccine's advantages still outweighed its risks.

"The National Vaccination Committee, after evaluating all available data, recommends the continuation of the vaccination programme with all available vaccines, including the AstraZeneca vaccine, to people aged 30 and over," the committee said in a statement.

The risk of a serious illness and death from COVID-19 "overwhelmingly" outweighed the risk of a possible blood clot following vaccination, especially for ages over 30, it said.

Greece has reported 288,230 cases of COVID-19 and a total of 8,680 deaths. It has administered 378,997 doses of the AstraZeneca vaccine so far and ordered another 1.35 million doses.

It has also used the Pfizer and Moderna COVID-19 vaccines to inoculate more than 2 million people.

Vaccination programmes have stuttered in Europe and elsewhere in the last month, since a very few mostly young recipients of the AstraZeneca shot were found to have suffered extremely unusual blood clots, leading some countries to suspend its use as a precaution or restrict it to people above a certain age.

Germany was the first European country to recommend that people under 60 who have had a first AstraZeneca shot should receive a different product for their second dose.

Comments

Comments are closed for this article.